Fractional laser as treatment option for various pigment disorders

• Conditions: pigment disorders; spotted disease; 10035023

• Registration Number: NL-OMON33568
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

Melasma and postinflammatory hyperpigmentation : skin photo type I-V ;
Becker naevus: skin photo type I-III ;
Ochronosis and ashy dermatosis : skin photo type IV-V ;
resistant Ota naevus: skin photo type III-IV ;
Subjects attending the outpatient department of the Netherlands Institute for Pigment Disorders;
Age at least 18 years;
Subject is willing and able to give written informed consent.

Exclusion Criteria

Bleaching cream during the past 6 weeks;
Local corticosteroids during the past 6 weeks;
Subjects with a history of keloid;
Subjects with active eczema;
Subjects with active acne in the face;
Subjects with a history of facial eczema;
Suspect allergy to lidocaine or triple therapy;
Use of roaccutane in the past 6 months;
Subjects not competent to understand what is involved;
Pregnancy;
Lesion suspicious for malignancy;
High exposure to sunlight (vacation in southern countries) or UV light (UVA or UVB).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Objective colour measurements by physician*s global assessment (PhGA),<br /><br>reflectance spectroscopy, clinical melasma score (MASI), patient*s<br /><br>satisfaction, patient*s global assessment (PGA), and visual assessment of side<br /><br>effects.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>